Cargando…
TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine
Migraine is a chronic neurological disorder that affects approximately 12% of the population. The cause of migraine headaches is not yet known, however, when the trigeminal system is activated, neuropeptides such as calcitonin gene-related peptide (CGRP) and substance P (SP) are released, which caus...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820749/ https://www.ncbi.nlm.nih.gov/pubmed/36614146 http://dx.doi.org/10.3390/ijms24010700 |
_version_ | 1784865536462553088 |
---|---|
author | Spekker, Eleonóra Körtési, Tamás Vécsei, László |
author_facet | Spekker, Eleonóra Körtési, Tamás Vécsei, László |
author_sort | Spekker, Eleonóra |
collection | PubMed |
description | Migraine is a chronic neurological disorder that affects approximately 12% of the population. The cause of migraine headaches is not yet known, however, when the trigeminal system is activated, neuropeptides such as calcitonin gene-related peptide (CGRP) and substance P (SP) are released, which cause neurogenic inflammation and sensitization. Advances in the understanding of migraine pathophysiology have identified new potential pharmacological targets. In recent years, transient receptor potential (TRP) channels have been the focus of attention in the pathophysiology of various pain disorders, including primary headaches. Genetic and pharmacological data suggest the role of TRP channels in pain sensation and the activation and sensitization of dural afferents. In addition, TRP channels are widely expressed in the trigeminal system and brain regions which are associated with the pathophysiology of migraine and furthermore, co-localize several neuropeptides that are implicated in the development of migraine attacks. Moreover, there are several migraine trigger agents known to activate TRP channels. Based on these, TRP channels have an essential role in migraine pain and associated symptoms, such as hyperalgesia and allodynia. In this review, we discuss the role of the certain TRP channels in migraine pathophysiology and their therapeutic applicability. |
format | Online Article Text |
id | pubmed-9820749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98207492023-01-07 TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine Spekker, Eleonóra Körtési, Tamás Vécsei, László Int J Mol Sci Review Migraine is a chronic neurological disorder that affects approximately 12% of the population. The cause of migraine headaches is not yet known, however, when the trigeminal system is activated, neuropeptides such as calcitonin gene-related peptide (CGRP) and substance P (SP) are released, which cause neurogenic inflammation and sensitization. Advances in the understanding of migraine pathophysiology have identified new potential pharmacological targets. In recent years, transient receptor potential (TRP) channels have been the focus of attention in the pathophysiology of various pain disorders, including primary headaches. Genetic and pharmacological data suggest the role of TRP channels in pain sensation and the activation and sensitization of dural afferents. In addition, TRP channels are widely expressed in the trigeminal system and brain regions which are associated with the pathophysiology of migraine and furthermore, co-localize several neuropeptides that are implicated in the development of migraine attacks. Moreover, there are several migraine trigger agents known to activate TRP channels. Based on these, TRP channels have an essential role in migraine pain and associated symptoms, such as hyperalgesia and allodynia. In this review, we discuss the role of the certain TRP channels in migraine pathophysiology and their therapeutic applicability. MDPI 2022-12-31 /pmc/articles/PMC9820749/ /pubmed/36614146 http://dx.doi.org/10.3390/ijms24010700 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Spekker, Eleonóra Körtési, Tamás Vécsei, László TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine |
title | TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine |
title_full | TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine |
title_fullStr | TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine |
title_full_unstemmed | TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine |
title_short | TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine |
title_sort | trp channels: recent development in translational research and potential therapeutic targets in migraine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820749/ https://www.ncbi.nlm.nih.gov/pubmed/36614146 http://dx.doi.org/10.3390/ijms24010700 |
work_keys_str_mv | AT spekkereleonora trpchannelsrecentdevelopmentintranslationalresearchandpotentialtherapeutictargetsinmigraine AT kortesitamas trpchannelsrecentdevelopmentintranslationalresearchandpotentialtherapeutictargetsinmigraine AT vecseilaszlo trpchannelsrecentdevelopmentintranslationalresearchandpotentialtherapeutictargetsinmigraine |